University of Surrey

Test tubes in the lab Research in the ATI Dance Research

EN2 in Prostate Cancer.

McGrath, SE, Michael, A, Morgan, R and Pandha, H (2015) EN2 in Prostate Cancer. Adv Clin Chem, 71. pp. 47-76.

Full text not available from this repository.


Despite extensive efforts to identify a clinically useful diagnostic biomarker in prostate cancer, no new test has been approved by regulatory authorities. As a result, this unmet need has shifted to biomarkers that additionally indicate presence or absence of "significant" disease. EN2 is a homeodomain-containing transcription factor secreted by prostate cancer into the urine and can be detected by enzyme-linked immunoassay. EN2 may be an ideal biomarker because normal prostate tissue and benign prostatic hypertrophic cells do not secrete EN2. This review discusses the enormous potential of EN2 to address this unmet need and provide the urologist with a simple, inexpensive, and reliable prostate cancer biomarker.

Item Type: Article
Authors :
Date : 2015
Identification Number : 10.1016/bs.acc.2015.06.002
Uncontrolled Keywords : Biomarker, Engrailed 2, Prostate cancer, Significant disease, Biomarkers, Tumor, Homeodomain Proteins, Humans, Male, Nerve Tissue Proteins, Prostatic Neoplasms, Risk Factors
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 10:34
Last Modified : 17 May 2017 14:50

Actions (login required)

View Item View Item


Downloads per month over past year

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800